YS Biopharma Receives Additional 180 Day Extension by Nasdaq

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , China , Philippines , Singapore , Robin Yang , Alyssa Li , Securities Exchange , Nasdaq Stock Market , Prnewswire Ys Biopharma Co Ltd , Rsys Group , Nasdaq , Source Ys Biopharma Co Ltd , Exchange Commission , Company Registration Statement On Form , Receives Additional , Regain Compliance , Minimum Bid Price , Nasdaq Listing Rule , Nasdaq Capital Market , Bid Price Requirement , Bid Price , Extension Notice , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Post Effective Amendment , Registration Statement ,